|
|
|
|
|
| September 30,
2010 | ISSUE NUMBER 168 VOL 8 |
Research
Economics of Alzheimer’s Disease Prove Shocking
The global burden of caring for people with dementia is so big that its costs now exceed total annual health spending in the world’s five largest economies outside the US.
Deals
Endo Pharmaceuticals Acquires Qualitest for $1.2 Billion
The biotech aims to deliver with this deal more comprehensive healthcare solutions across its diversified businesses in branded pharmaceuticals, generics, and devices & services in key therapeutic areas.
Clinical Trials
Pfizer Ends Sutent Trial
Successful cancer drug Sutent may not be effective in prolonging life for patients with castration-resistant prostate cancer.
New Ventures
Oracle Launches Oracle Health Sciences Institute
The ability to develop the right technology to support patient needs and anticipate changes in the health sciences industry is pivotal in advancing how next-generation healthcare will be defined and administered.
|
|
 // AbelsonTaylor hired Jamie Wertheimer as senior account supervisor and promoted Angela Severance to account executive. // Dutch biotechnology company Mucosis B.V. has elected John Lambert as member and chair of its Supervisory Board. // OSO BioPharmaceuticals Manufacturing (Albuquerque, N.M.) has named Susan Schniepp as vice president of quality. // The Society of Pharmaceutical and Biotech Trainers (SPBT) has named Kevin Kruse as new executive director, effective Oct. 1. // AIKO Biotechnology (Portland, Maine) has announced the appointment of Jim New, PhD, as CEO, and the appointment of Paul Goldenheim, M.D., as board director. // |
|
| |
|
3-D Segmentation: Managing your Brand’s Three Most Important Influencers
Thursday, Oct. 7, at 12 P.M. Eastern; 9 A.M. Pacific
Register Free at http://pharmexec.com/geo |
| |
|
Sep 29–30 6th Annual Bio/Pharmaceutical and Medical Device Product Recalls Summit
Washington, DC
Oct 20–21 Innovative Contracting for Bio/Pharmaceuticals
London, UK
Nov 4th SharePoint User Workshop for the Life Sciences Industry
Princeton, NJ.
Dec 8–9 CMAC 2010 - Commercialization and Market Access Congress
Orlando, FL |
|
|
|
|
 |
|
 |
|
 |
| Are FDA’s plans to collaborate with Medicare on drug approval decisions a good thing? |
|
|
|
|
You
are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To
ensure delivery to your Inbox, please add us to your
address book. If you need help doing this, click
here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
